The initial lawsuit was filed in 2015 by the Dan Abrams Co., which alleged that Medtronic represented certain spine devices that could only be used in the cervical spine as being applicable to the thoracolumbar spine in an FDA clearance application as a class 2 device. The devices needed FDA clearance to receive Medicare reimbursement.
A federal district court in California ruled in favor of Medtronic in 2019, and plaintiffs appealed. The circuit court reversed the district court’s decision.
The two parties agreed to settle the dispute Oct. 31, informing the court in a Nov. 27 stipulation of dismissal.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
